{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-040311","form_type":"8-K","ticker":"FEED","cik":"0001326706","company_name":"ENvue Medical, Inc.","filed_at":"2024-10-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.117619+00:00","generated_at":"2026-05-30T19:05:09.882079+00:00","sec_items":["5.08"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"NanoVibronix sets 2024 annual meeting for Dec 19; shareholder proposal deadline Oct 17","bullets":["2024 Annual Meeting of Stockholders scheduled for Thursday, December 19, 2024.","Record date for voting is close of business on October 28, 2024.","Deadline for Rule 14a-8 shareholder proposals and director nominations is October 17, 2024.","Universal proxy rule compliance notice also due by October 17, 2024.","Meeting date changed by more than 30 days from prior year's anniversary."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-040311","json":"https://secwatch.observer/filing/0001493152-24-040311.json","markdown":"https://secwatch.observer/filing/0001493152-24-040311.md","text":"https://secwatch.observer/filing/0001493152-24-040311.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326706/000149315224040311/0001493152-24-040311-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326706/000149315224040311/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T19:05:09.882079+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}